|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 15 June 2004
doi: 10.1242/jcs.01188
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |

1 Department of Oral Surgery, Medicine and Pathology, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XY, UK
2 Cardiff Institute of Tissue Engineering and Repair, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XY, UK
3 Matrix Biology and Tissue Repair Research Unit, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XY, UK
4 Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XY, UK
5 Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XY, UK
6 Connective Tissue Biology Laboratories, School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3US, UK
Author for correspondence (e-mail: aeschlimanndp{at}cardiff.ac.uk)
Accepted 26 February 2004
Tissue transglutaminase (TG2) affects cell-matrix interactions in cell spreading, migration and extracellular matrix (ECM) reorganisation. Using fibroblasts deficient in TG2 or overexpressing normal or crosslinking-deficient enzyme, we show that the extracellular crosslinking activity and intracellular G-protein function in signal transduction contribute differentially to regulation of cell-matrix interactions. TG2-deficient cells displayed normal attachment but delayed spreading on ECM substrata and defects in motility unrelated to crosslinking. Blocking antibodies to TG2 failed to induce similar defects in normal fibroblasts. TG2-deficient fibroblasts had defects in focal adhesion turnover and stress fibre formation, showed changes in focal adhesion kinase (FAK) phosphorylation and failed to activate protein kinase C
(PKC
). Phospholipase C (PLC) and PKC
inhibitors blocked spreading of normal fibroblasts whilst PKC activators induced spreading in TG2-deficient cells. In contrast, ECM remodelling was not only compromised by TG2 deficiency but also by overexpression of dominant negative enzyme and TG inhibitors. TG2 activity increased matrix tension and was required for membrane type 1-MMP (MT1-MMP)-dependent activation of MMP-2. Our results demonstrate that TG2 is involved in the control of dynamic adhesion formation in cell spreading and migration via regulation of phospholipase C activity. By virtue of its crosslinking activity, the enzyme plays a central role in regulating ECM remodelling.
Key words: Transglutaminase, Cell adhesion, Wound healing, Signalling
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
A. Scarpellini, R. Germack, H. Lortat-Jacob, T. Muramatsu, E. Billett, T. Johnson, and E. A. M. Verderio Heparan Sulfate Proteoglycans Are Receptors for the Cell-surface Trafficking and Biological Activity of Transglutaminase-2 J. Biol. Chem., July 3, 2009; 284(27): 18411 - 18423. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. CHHABRA, A. VERMA, and K. MEHTA Tissue Transglutaminase Promotes or Suppresses Tumors Depending on Cell Context Anticancer Res, June 1, 2009; 29(6): 1909 - 1919. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Hwang, L. S. Mangala, J. Y. Fok, Y. G. Lin, W. M. Merritt, W. A. Spannuth, A. M. Nick, D. J. Fiterman, P. E. Vivas-Mejia, M. T. Deavers, et al. Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma Cancer Res., July 15, 2008; 68(14): 5849 - 5858. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Fiedler, E. Schonherr, R. Waddington, S. Niland, D. G. Seidler, D. Aeschlimann, and J. A. Eble Decorin Regulates Endothelial Cell Motility on Collagen I through Activation of Insulin-like Growth Factor I Receptor and Modulation of {alpha}2{beta}1 Integrin Activity J. Biol. Chem., June 20, 2008; 283(25): 17406 - 17415. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-C. Hsu, S.-Y. Chiang, C.-Y. Huang, G. J. Tsay, C.-W. Yang, C.-N. Huang, and B.-S. Tzang Beneficial Effects of Treatment with Transglutaminase Inhibitor Cystamine on Macrophage Response in NZB/W F1 Mice Experimental Biology and Medicine, February 1, 2007; 232(2): 195 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Balajthy, K. Csomos, G. Vamosi, A. Szanto, M. Lanotte, and L. Fesus Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions Blood, September 15, 2006; 108(6): 2045 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Amatangelo, D. E. Bassi, A. J.P. Klein-Szanto, and E. Cukierman Stroma-Derived Three-Dimensional Matrices Are Necessary and Sufficient to Promote Desmoplastic Differentiation of Normal Fibroblasts Am. J. Pathol., August 1, 2005; 167(2): 475 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Johnson and R. A. Terkeltaub External GTP-bound Transglutaminase 2 Is a Molecular Switch for Chondrocyte Hypertrophic Differentiation and Calcification J. Biol. Chem., April 15, 2005; 280(15): 15004 - 15012. [Abstract] [Full Text] [PDF] |
||||